The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal ...

A study highlights significant body composition changes and increased cardiovascular risks in transgender men on testosterone ...

Women with oestrogen-sensitive breast cancer now receive anti-hormonal therapy. Researchers have discovered that ...

In patients with hormone-sensitive breast cancer tumor growth is mainly driven by estrogen and patients are therefore treated with estrogen-suppressing drugs, often tamoxifen. However, anti-hormonal ...

Today, women with oestrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk ...

Women with oestrogen-sensitive breast cancer now receive anti-hormonal therapy. Researchers have discovered that postmenopausal women with low-risk tumours have a long-term benefit for at least 20 ...

The new research program will look at ways to reduce risks of heart disease, hormone delays and other late-term effects of ...

Say goodbye to donor cycles? This game-changing therapy may hold the key to reverse infertility and may be the solution to ...

The Supreme Court heard oral arguments on Wednesday on a Tennessee bill that bans transgender minors from certain forms of ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...